We are live on ! Find out more
ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.7B
1-Year Est. Return 340.85%
This Fund
S&P 500
This Quarter Est. Return
+150.31%
1 Year Est. Return
+340.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
+$412M
Cap. Flow
+$25.7M
Cap. Flow %
2.41%
Top 10 Hldgs %
48.66%
Holding
270
New
60
Increased
70
Reduced
50
Closed
53

Top Buys

Rank Stock Value
1
IMVT icon
Immunovant
IMVT
+$27.6M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.5M
3
ROIV icon
Roivant Sciences
ROIV
+$17.4M
4
ETNB
89bio
ETNB
+$12.6M
5
JANX icon
Janux Therapeutics
JANX
+$7.04M

Top Sells

Rank Stock Value
1
ABVX
Abivax
ABVX
+$105M
2
PRTA icon
Prothena Corp
PRTA
+$14.6M
3
CGON icon
CG Oncology
CGON
+$7.97M
4
SAGE
Sage Therapeutics
SAGE
+$6.58M
5
VERV
Verve Therapeutics
VERV
+$5.27M

Sector Composition

Rank Sector Weight
1 Healthcare 83.19%
2 Financials 1.65%
3 Communication Services 0.09%
4 Consumer Discretionary 0.09%
5 Technology 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNXT icon
251
RenovoRx
RNXT
$50.5M
– –
-19,889
Closed -$26.2K
SAGE
252
DELISTED
Sage Therapeutics
SAGE
– –
-721,599
Closed -$6.58M
SHY icon
253
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
– –
-53,337
Closed -$4.42M
SMMT icon
254
CALL
Summit Therapeutics
SMMT
$11.1B
– –
-100,000
Closed -$2.13M
SNDX icon
255
Syndax Pharmaceuticals
SNDX
$1.82B
– –
-10,000
Closed -$93.7K
SRPT icon
256
CALL
Sarepta Therapeutics
SRPT
$1.77B
– –
-55,000
Closed -$941K
STOK icon
257
Stoke Therapeutics
STOK
$2.11B
– –
-27,285
Closed -$310K
STTK icon
258
Shattuck Labs
STTK
$694M
– –
-102,948
Closed -$81.5K
SWTX
259
DELISTED
SpringWorks Therapeutics
SWTX
– –
-24,082
Closed -$1.13M
THRD
260
DELISTED
Third Harmonic Bio
THRD
– –
-622,873
Closed -$3.38M
TRVI icon
261
Trevi Therapeutics
TRVI
$2.64B
– –
-30,000
Closed -$164K
VERV
262
DELISTED
Verve Therapeutics
VERV
– –
-469,018
Closed -$5.27M
VIR icon
263
Vir Biotechnology
VIR
$1.49B
– –
-250,000
Closed -$1.26M
UCFI
264
CN Healthy Food Tech Group
UCFI
– –
-25,000
Closed -$258K
IROHR
265
DELISTED
Iron Horse Acquisitions Corp Right
IROHR
– –
-12,320
Closed -$6.14K
JVSAR
266
DELISTED
JV SPAC Acquisition Corp. Right
JVSAR
– –
-24,000
Closed -$20.9K
AAM.WS
267
DELISTED
AA Mission Acquisition Corp Warrants
AAM.WS
– –
-505,099
Closed -$49.7K
OKUR
268
OnKure Therapeutics
OKUR
$168M
– –
-10,000
Closed -$23.9K
7 8 9 10
11

Similar funds

RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
II
Inspire Investing Meridian, Idaho $1.71B AUM 31.76% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

ADAR1 Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, ADAR1 Capital Management held 270 positions worth $1.06B, up 63% from $652M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

ADAR1 Capital Management's Q3 2025 filing shows 60 new, 70 increased, 50 reduced and 53 closed positions. Its largest new stake was Invivyd: 7,370,987 shares worth $8.11M. The largest sale was Abivax, an estimated $105M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, up from 79% a quarter earlier, followed by Financials and Communication Services.

  • ADAR1 Capital Management's largest Q3 2025 buy was Invivyd: 7,370,987 shares worth $8.11M.
  • ADAR1 Capital Management added most to Immunovant in Q3 2025, an estimated $27.6M increase.
  • ADAR1 Capital Management's biggest Q3 2025 reduction was Abivax, cutting an estimated $105M.
  • ADAR1 Capital Management fully exited Sage Therapeutics in Q3 2025, selling an estimated $6.58M.
  • ADAR1 Capital Management's ten largest holdings make up 49% of its $1.06B portfolio in Q3 2025.
  • ADAR1 Capital Management opened 60 new positions and closed 53 in Q3 2025.
  • ADAR1 Capital Management's portfolio value rose 63% quarter-over-quarter to $1.06B.

Based on ADAR1 Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.